Registro completo |
Provedor de dados: |
60
|
País: |
Brazil
|
Título: |
Use of unlicensed and off-label drugs in neonates in a Brazilian university hospital
|
Autores: |
Gonçalves,Adriana Cristina de Souza
Reis,Adriano Max Moreira
Marçal,Ana Carolina Gusmão
Bouzada,Maria Cândida Ferrarez
|
Data: |
2017-01-01
|
Ano: |
2017
|
Palavras-chave: |
Drugs/use/University Hospital/Brazil
Drug/use/off-label/unlicensed
Drug therapy
Neonatology
University Hospital/Brazil.
|
Resumo: |
ABSTRACT This study was designed to investigate the use of off-label and unlicensed drugs in a Neonatal Care Unit (NCU) and to compare the frequency of use of off-label drugs according to the drug regulatory agencies in Brazil (Agência Nacional de Vigilância Sanitária-ANVISA) and the United States Food and Drug Administration (FDA). A prospective observational study was carried out in the NCU. Prescriptions were classified as off-label and unlicensed using both ANVISA and FDA criteria. A total of 157 newborns and 1187 prescriptions were analyzed. The most prescribed drug was fentanyl (9.3%), followed by multivitamin (8.4%) and gentamicin (7.9%). According to ANVISA criteria, there were 665 (56.0%) off-label prescriptions and 86 (7.2%) unlicensed prescriptions and 95.5% of newborns received at least one drug off-label. By contrast, according to FDA criteria, there were 592 (49.9%) off-label prescriptions and 84 (7.1%) unlicensed prescriptions, and 72.0% of newborns received at least one drug off-label. The off-label use of drugs registered by ANVISA differed significantly from that of drugs registered by the FDA. There was a high frequency of off-label and unlicensed drug use in the investigated NCU, and there was an inverse relationship between off-label and unlicensed usage and the gestational age of the newborns.
|
Tipo: |
Info:eu-repo/semantics/article
|
Idioma: |
Inglês
|
Identificador: |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000300622
|
Editor: |
Universidade de São Paulo, Faculdade de Ciências Farmacêuticas
|
Relação: |
10.1590/s2175-97902017000300252
|
Formato: |
text/html
|
Fonte: |
Brazilian Journal of Pharmaceutical Sciences v.53 n.3 2017
|
Direitos: |
info:eu-repo/semantics/openAccess
|